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Myxoma is the most common primary tumor of the heart. The rarity of infected cardiac myxomas leads to numerous diagnostic
and therapeutic diﬃculties. We present a case of infected left atrial myxoma caused by methicillin-sensible Staphylococcus aureus
in a 48-year-old woman complicated by systemic embolism and septic shock.
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1.Introduction
Myxomas are the most common primary tumors of the
heart in adults, which have an estimated incidence of 0.5per
million population per year [1].
The most common clinical presentation is symptoms of
mitral valve stenosis or peripheral embolism. The rarity of
infected cardiac myxomas leads to numerous diagnostic and
therapeutic diﬃculties. We report a case of infected left atrial
myxoma in a 48-year-old woman complicated by systemic
embolism and septic shock.
2.ClinicalSummary
A 46-year-old woman, presented with subacute dyspnea,
maintained fevers for 3 weeks of unkoun origin and fatigue.
She had diabetes mellitus and no history of recent surgical or
dental intervention or drug abuse.
In the physical examination, the patient appeared ill,
cachectic, and tachypneic. She presented a blood pressure of
80/50mmHg, a heart rate of 120beats/min and a tempera-
ture of 38.2
◦C. She had jugular venous distention with pos-
itive hepatojugular reﬂux and normal heart sounds without
murmurs. Examination of the lungs revealed coarse bilateral
breath sounds with inspiratory basal crackles. Abdominal
examination revealed no organomegaly; extremities had
mildbilateraledema.Theremainingexaminationshowedno
abnormalities.
Electrocardiogram showed sinus tachycardia with an
incomplete right bundle-branch block. Chest radiography
was normal. Hematologic laboratory values revealed anemia
(haemoglobin: 9g/dL), leukocytosis white blood cell count:
23000/mm3, an erythrocyte sedimentation rate (ESR) of
100mm/h, CRP was 64mg/L, and urine analysis showed no
abnormalities.
Transthoracic echocardiography and transesophageal
echocardiography (Figure 1) revealed a large heterogeneous
density tumor in the left atrium, measured about 6 ∗ 5cm
in length adhering to the interatrial septum, with prolapse in
the left ventricle. The estimated pulmonary artery pressures
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the mitral valve showed a trace of regurgitation and the
left ventricle was hyperkinetic with an estimated ejection
fraction of 55%.
Empirical antibiotic therapy with vancomycine and
gentamicin was started, surgical treatment was postponed,
and blood was drawn for cultures, which were positive for
methicillin-sensible Staphylococcus aureus. There is no other
source of infection; therefore, the atrial mass was suspected
to be the cause of sepsis. The patient’s hospital course was
complicated on day 3 by thrombo embolism cerebral attacks,
and then urgent surgical removal was scheduled on the
seventh day of hospitalization.2 Case Reports in Medicine
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Figure 1: Transesophageal echocardiography revealing large het-
erogeneous density tumor in the left atrium.
The patient underwent surgical excision of the mass,
which was found to be a myxoma inﬁltrated with abundant
inﬂammatory cells, the cultures of the myxoma which were
positive for methicillin-sensible Staphylococcus aureus.S h e
died 10 days after surgical intervention by disseminated
intravascular coagulation.
3. Discussion
Primary cardiac tumors represent less than 0.2% of all
neoplasms, three quarters of the tumors are benign, and
half of these are myxomas [2]. Myxomas are more common
among women and can aﬀect both atria, the ventricles, or
the mitral valve; the left atrium is most commonly involved
[3, 4].
The most common manifestations are dyspnea and
central nervous system embolization; whereas Dias et al. [5]
reported peripheral embolism to be dominant. An increased
incidence of distal embolization, fever, cachexia, Raynaud
phenomenon, or signs of mitral stenosis was noticed by
Pinede et al. [6].
Although there have been several reports of infected
myxomas in the recent years, they remain a rare entity [7–
10]; a recent literature review, revealed 40 deﬁnitive cases of
infected myxomas [11].
They can be challenging to diagnose because of their rare
occurrence and varied clinical presentation in fact infected
and uninfected myxomas; endocardiac thrombus and endo-
carditis may exhibit the same symptoms (fever, weight loss,
fatigue, and malaise) making the correct diagnosis diﬃcult.
These systemic symptoms in myxoma, anemia, and raised
ESR could be due to the systemic eﬀects of interleukin
6, the cytokine implicated in generating a generalized
inﬂammatoryresponseinpatientswithmyxomas,withlevels
decreasing after tumor excision [1, 12, 13], then criteria
have been proposed by Revankar and Clark [14] to aid in
the diagnosis of infected myxoma and they stated that the
diagnosis is certain in the presence of myxoma documented
by histology, and microorganisms observed in the sample, or
apositivebloodculturesandevidenceofinﬂammationinthe
sample.
In our case, the documented myxoma as evidenced by
clinical examination, pathology, and positive blood cultures
qualiﬁes this case as a “deﬁnite” infected cardiac myxoma.
The microorganisms involved were Streptococcus viridians
(44%) and Staphylococcus aureus (15%), a microbiological
spectrum similar to that of native valve endocarditis [15].
Systemic embolization occurs in 30% to 40% of patients
with myxomas; infected cardiac myxomas are more dan-
gerous than noninfected myxomas and their incidence of
embolization is increased two- to threefold [14, 16].
Little is known of the correct strategy for treatment of
an infected myxoma; surgical excision of cardiac myxoma
carries a low operative risk and gives excellent short-term
and long-term results.Surgical excision of the tumor appears
to be curative, with few recurrences at long-term followup.
After diagnosis, surgery should be performed urgently, in
order to prevent complications such as embolic events or
obstruction of the mitral oriﬁce.
But there is a dilemma between the urgency to prevent
the embolic complications and the need for a surgery
on sterile tumor and it seems advisable to recommend
surgery despite active infection in an attempt to prevent a
catastrophic embolization [8, 9, 17].
We conclude that infective left atrial mxoma is an
extremely rare condition. The diagnosis is diﬃcult, and
because it has such a high incidence of embolization,
emergency surgery should be done to remove this type of
myxoma once it is diagnosed.
References
[ 1 ]S .A .G r e g o r y ,W .T .O ’ B y r n eI I I ,a n dP .F a n ,“ I n f e c t e dc a r d i a c
myxoma,” Echocardiography, vol. 21, no. 1, pp. 65–67, 2004.
[2] K. Reynen, “Cardiac myxomas,” The New England Journal of
Medicine, vol. 333, no. 24, pp. 1610–1617, 1995.
[ 3 ]M .F .J i m ´ enez-Navarro, J. C. Gavil´ a n ,J .M .M e l e r o ,e ta l . ,
“Mixoma de gran tama˜ no en la aur´ ıcula derecha,” Revista
Espanola de Cardiologia, vol. 54, no. 3, pp. 399–401, 2001.
[ 4 ]A .R .M o r e n o ,M .A .S ´ anchez, J. C. Castillo Dom´ ınguez, et
al., “Mixoma ventricular izquierdo aislado descubierto casual-
mente por ecocardiograf´ ıa,” Revista Espanola de Cardiologia,
vol. 51, no. 9, pp. 763–765, 1998.
[5] R.R.Dias,N.A.G.Stolf,L.M.Malbouisson,etal.,“Morbidity
and embolic potential of left atrial cardiac tumors,” Thoracic
and Cardiovascular Surgeon, vol. 54, no. 6, pp. 400–403, 2006.
[6] L. Pinede, P. Duhaut, and R. Loire, “Clinical presentation of
left atrial cardiac myxoma: a series of 112 consecutive cases,”
Medicine, vol. 80, no. 3, pp. 159–172, 2001.
[ 7 ]J .M .t e nB e r g ,H .R .J .E l b e r s ,J .J .A .M .D e f a u w ,a n dH .W .
T. Plokker, “Endocarditis on a left atrial myxoma,” European
Heart Journal, vol. 13, no. 11, pp. 1592–1593, 1992.
[ 8 ]M .S .W h i t m a n ,M .A .R o v i t o ,D .K l i o n s ,a n dA .R .T u n k e l ,
“Infected atrial myxoma: case report and review,” Clinical
Infectious Diseases, vol. 18, no. 4, pp. 657–658, 1994.
[9] A. Garc´ ıa-Quintana, P. Mart´ ın-Lorenzo, J. Su´ arez de Lezo, M.
D´ ıaz-Escofet, R. Llorens, and A. Medina, “Infected left atrial
myxoma,” Revista Espanola de Cardiologia, vol. 58, no. 11, pp.
1358–1360, 2005.Case Reports in Medicine 3
[10] P. Dekkers, H. R. J. Elbers, W. J. Morshuis, and W. Jaarsma,
“Infected left atrial myxoma,” Journal of the American Society
of Echocardiography, vol. 14, no. 6, pp. 644–645, 2001.
[11] S. K. Aggarwal, R. Barik, T. C. S. R. Sarma, et al., “Clinical
presentation and investigation ﬁndings in cardiac myxomas:
new insights from the developing world,” American Heart
Journal, vol. 154, no. 6, pp. 1102–1107, 2007.
[12] T. Saji, E. Yanagawa, H. Matsuura, et al., “Increased serum
interleukin-6 in cardiac myxoma,” American Heart Journal,
vol. 122, no. 2, pp. 579–580, 1991.
[13] C. E. Mendoza, M. F. Rosado, and L. Bernal, “The role of
interleukin-6 in cases of cardiac myxoma: clinical features,
immunologic abnormalities, and a possible role in recur-
rence,” Texas Heart Institute Journal, vol. 28, no. 1, pp. 3–7,
2001.
[14] S. G. Revankar and R. A. Clark, “Infected cardiac myxoma:
case report and literature review,” Medicine, vol. 77, no. 5, pp.
337–344, 1998.
[15] M. Luaces M´ endez, I. Vilacosta, C. Sarri´ a, et al., “Endocarditis
infecciosa y embolias del eje hepatoesplenorrenal,” Revista
Espanola de Cardiologia, vol. 57, no. 12, pp. 1188–1196, 2004.
[ 1 6 ]M .G .R i a d ,J .D .P a r k s ,P .B .M u r p h y ,a n dD .T h a n g a t h u r a i ,
“Infectedatrialmyxomapresentingwithsepticshock,”Journal
of Cardiothoracic and Vascular Anesthesia, vol. 19, no. 4, pp.
508–511, 2005.
[17] W. Kuroczy´ nski, A. A. Peivandi, P. Ewald, D. Pruefer, M.
Heinemann, and C.-F. Vahl, “Cardiac myxomas: short- and
long-term follow-up,” Cardiology Journal,v o l .1 6 ,n o .5 ,p p .
447–454, 2009.